The Centre Pasteur du Cameroun is pleased to highlight the work of its researchers, biologists, and technicians through the publication of the article: “High proportion of hepatitis B virus-infected patients at a mild stage of disease progression: a cross-sectional study in a single reference laboratory in Cameroon.”

This study, based on the records of 1,652 patients followed between 2011 and 2021, reveals a key finding: more than 60% of patients have a mildly progressive form of chronic HBV infection (stage 3 according to the EASL classification).
  Some key figures:
68.5% have a low viral load (<2000 IU/mL)
90.1% are HBeAg negative
65.5% have normal transaminases
Median age: 31 years (women) / 33 years (men)
Why is this important? Hepatitis B remains a major public health issue, yet only 1% of infected people are diagnosed in Africa. These data show that early screening and clinical monitoring are essential to prevent serious complications (cirrhosis, liver cancer) and improve treatment.
To read the full article: https://pubmed.ncbi.nlm.nih.gov/40727502/